LumiraDx Limited (LMDXW) Stock Analysis
NASDAQHealthcareMedical - Diagnostics & Research
What LumiraDx Limited does
Specializing in point-of-care diagnostics, LumiraDx Limited endeavors to revolutionize community healthcare. It achieves this by equipping medical providers with crucial diagnostic information where and when they need it most. Established in 2002, the company was formerly known as Point of Care Testing Limited before officially adopting the name LumiraDx Ltd in January 2018. Its corporate headquarters are located in London, United Kingdom.
Key metrics
ETFs linked to LMDXW
Broad-market and Healthcare sector ETFs an investor holding LumiraDx Limited is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how LMDXW fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze LMDXW in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for LumiraDx Limited?
- LumiraDx Limited trades under the ticker LMDXW on NASDAQ.
- Which exchange is LMDXW listed on?
- LMDXW is listed on NASDAQ.
- What sector does LumiraDx Limited operate in?
- LumiraDx Limited is classified in the Healthcare sector (Medical - Diagnostics & Research industry).
- How can PortView help analyze LMDXW in a portfolio?
- PortView shows LMDXW's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.